Voyager Therapeutics, Inc.
VYGR· Nasdaq
VYGRVoyager Therapeutics, Inc.
Filed Nov 10, 2016 · 10-Q · 41 days after period end · 0001558370-16-009940
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | $3.31M | $4.94M | — |
| Net Income | -$9.00M | -$3.92M | -$4.01M |
| EPS Diluted | $0.35 | $5.25 | $6.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 10, 2016 · 41 d after period end
